Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer
NCT02769104
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Neoadjuvant Therapy
Interventions
DRUG:
Letrozole (Aromatase Inhibitors)
DRUG:
AC*4-T*4
Sponsor
Zhejiang Cancer Hospital